| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 22 | 2024 | 1019 | 3.710 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2024 | 307 | 1.840 |
Why?
|
| Breast Neoplasms | 15 | 2022 | 1723 | 1.770 |
Why?
|
| Tamoxifen | 6 | 2016 | 69 | 1.770 |
Why?
|
| Drug Design | 10 | 2022 | 186 | 1.300 |
Why?
|
| Structure-Activity Relationship | 17 | 2024 | 506 | 1.220 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2015 | 47 | 1.170 |
Why?
|
| Cell Line, Tumor | 24 | 2024 | 2676 | 1.150 |
Why?
|
| Boronic Acids | 2 | 2020 | 21 | 1.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2020 | 31 | 1.120 |
Why?
|
| Pyridines | 3 | 2020 | 139 | 1.090 |
Why?
|
| Prodrugs | 4 | 2015 | 31 | 1.080 |
Why?
|
| Neoplasms | 7 | 2023 | 1377 | 1.040 |
Why?
|
| Cell Proliferation | 18 | 2024 | 1455 | 1.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 159 | 0.880 |
Why?
|
| Microsomes, Liver | 6 | 2013 | 75 | 0.840 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 139 | 0.810 |
Why?
|
| Proteomics | 7 | 2019 | 378 | 0.800 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 121 | 0.790 |
Why?
|
| Estrogens | 3 | 2019 | 203 | 0.780 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 257 | 0.760 |
Why?
|
| Estrogen Antagonists | 2 | 2013 | 30 | 0.730 |
Why?
|
| Drug Screening Assays, Antitumor | 10 | 2022 | 157 | 0.720 |
Why?
|
| Morpholines | 3 | 2010 | 72 | 0.720 |
Why?
|
| Molecular Structure | 12 | 2022 | 570 | 0.720 |
Why?
|
| Administration, Oral | 5 | 2024 | 260 | 0.640 |
Why?
|
| Drug Discovery | 2 | 2024 | 108 | 0.640 |
Why?
|
| Furans | 1 | 2020 | 40 | 0.620 |
Why?
|
| Mutation | 1 | 2024 | 1177 | 0.610 |
Why?
|
| Animals | 32 | 2024 | 16992 | 0.610 |
Why?
|
| Receptors, Estrogen | 5 | 2019 | 183 | 0.600 |
Why?
|
| Pyrimidines | 1 | 2020 | 139 | 0.590 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2010 | 38 | 0.560 |
Why?
|
| Triazoles | 2 | 2020 | 102 | 0.530 |
Why?
|
| Immunotherapy | 1 | 2019 | 144 | 0.530 |
Why?
|
| Thiazoles | 2 | 2015 | 76 | 0.520 |
Why?
|
| Mice | 15 | 2024 | 6644 | 0.520 |
Why?
|
| Pyrazoles | 3 | 2024 | 103 | 0.510 |
Why?
|
| Humans | 39 | 2024 | 43102 | 0.510 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2022 | 1124 | 0.510 |
Why?
|
| Sterols | 1 | 2016 | 24 | 0.500 |
Why?
|
| Anthracenes | 1 | 2016 | 15 | 0.490 |
Why?
|
| Cell Movement | 4 | 2019 | 655 | 0.480 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2015 | 1 | 0.470 |
Why?
|
| Anthraquinones | 1 | 2015 | 9 | 0.470 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2015 | 20 | 0.470 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 148 | 0.460 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 62 | 0.450 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 46 | 0.430 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 61 | 0.430 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.430 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2020 | 347 | 0.420 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 20 | 0.420 |
Why?
|
| Indoles | 2 | 2006 | 187 | 0.410 |
Why?
|
| Isoflavones | 2 | 2014 | 132 | 0.410 |
Why?
|
| Biological Availability | 3 | 2020 | 116 | 0.390 |
Why?
|
| Mesoderm | 2 | 2013 | 73 | 0.390 |
Why?
|
| Nitriles | 1 | 2013 | 81 | 0.390 |
Why?
|
| Prostatic Neoplasms | 6 | 2022 | 1092 | 0.370 |
Why?
|
| Water Pollutants, Chemical | 2 | 2012 | 171 | 0.370 |
Why?
|
| Tandem Mass Spectrometry | 7 | 2015 | 241 | 0.370 |
Why?
|
| Naphthalenes | 2 | 2020 | 38 | 0.360 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 44 | 0.350 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2015 | 465 | 0.340 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2012 | 46 | 0.330 |
Why?
|
| Indomethacin | 1 | 2010 | 25 | 0.330 |
Why?
|
| Female | 21 | 2022 | 24698 | 0.320 |
Why?
|
| Mice, Nude | 3 | 2020 | 408 | 0.320 |
Why?
|
| Rats | 9 | 2024 | 3735 | 0.310 |
Why?
|
| Signal Transduction | 7 | 2019 | 2157 | 0.300 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2008 | 4 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2008 | 8 | 0.300 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2014 | 72 | 0.290 |
Why?
|
| Epithelium | 1 | 2008 | 78 | 0.290 |
Why?
|
| Liver | 3 | 2017 | 511 | 0.290 |
Why?
|
| Receptors, Cannabinoid | 2 | 2004 | 31 | 0.270 |
Why?
|
| Sulfonamides | 2 | 2022 | 91 | 0.260 |
Why?
|
| Water Pollutants | 1 | 2006 | 17 | 0.250 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 384 | 0.250 |
Why?
|
| Neoplasm Proteins | 3 | 2013 | 228 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 968 | 0.250 |
Why?
|
| Rivers | 1 | 2006 | 51 | 0.240 |
Why?
|
| Lung | 3 | 2014 | 492 | 0.240 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 94 | 0.220 |
Why?
|
| Lactams | 1 | 2024 | 10 | 0.220 |
Why?
|
| Aminopyridines | 1 | 2024 | 26 | 0.220 |
Why?
|
| Piperidines | 1 | 2004 | 83 | 0.210 |
Why?
|
| Chick Embryo | 2 | 2014 | 79 | 0.210 |
Why?
|
| Hela Cells | 4 | 2022 | 376 | 0.210 |
Why?
|
| Models, Animal | 2 | 2015 | 151 | 0.200 |
Why?
|
| Berberine | 1 | 2023 | 9 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1869 | 0.200 |
Why?
|
| Curcumin | 2 | 2015 | 118 | 0.200 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 35 | 0.190 |
Why?
|
| Apoptosis | 7 | 2022 | 1568 | 0.190 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 290 | 0.190 |
Why?
|
| Models, Molecular | 4 | 2015 | 876 | 0.190 |
Why?
|
| Aza Compounds | 1 | 2022 | 11 | 0.190 |
Why?
|
| Spiro Compounds | 1 | 2022 | 16 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2016 | 456 | 0.190 |
Why?
|
| Receptors, Drug | 1 | 2002 | 61 | 0.190 |
Why?
|
| Ligands | 3 | 2022 | 388 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 99 | 0.180 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 99 | 0.180 |
Why?
|
| Cannabinoids | 1 | 2002 | 73 | 0.180 |
Why?
|
| Proteome | 2 | 2013 | 152 | 0.180 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 144 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2019 | 78 | 0.170 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 78 | 0.160 |
Why?
|
| Geologic Sediments | 2 | 2012 | 46 | 0.160 |
Why?
|
| Peroxidase | 1 | 2019 | 57 | 0.150 |
Why?
|
| Oxazoles | 1 | 2019 | 19 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2013 | 883 | 0.150 |
Why?
|
| Chromatography, Liquid | 3 | 2013 | 182 | 0.140 |
Why?
|
| Adipocytes | 1 | 2019 | 60 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2017 | 462 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 127 | 0.140 |
Why?
|
| Acetaminophen | 1 | 2018 | 30 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 35 | 0.140 |
Why?
|
| Stem Cells | 1 | 2019 | 152 | 0.140 |
Why?
|
| Arginine | 1 | 2018 | 75 | 0.140 |
Why?
|
| Cell Death | 2 | 2015 | 278 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2015 | 140 | 0.130 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 237 | 0.130 |
Why?
|
| Hydroxides | 1 | 2016 | 9 | 0.130 |
Why?
|
| Nickel | 1 | 2016 | 23 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 66 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2017 | 33 | 0.130 |
Why?
|
| Xanthine Oxidase | 1 | 2016 | 9 | 0.120 |
Why?
|
| Aluminum | 1 | 2016 | 39 | 0.120 |
Why?
|
| Allopurinol | 1 | 2016 | 13 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 47 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 40 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 77 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2016 | 169 | 0.120 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.120 |
Why?
|
| Fluorocarbons | 1 | 2016 | 42 | 0.120 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 57 | 0.120 |
Why?
|
| Pentanones | 1 | 2015 | 4 | 0.120 |
Why?
|
| Aminophenols | 1 | 2015 | 2 | 0.120 |
Why?
|
| Estradiol | 3 | 2014 | 268 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 28 | 0.120 |
Why?
|
| Agaricales | 1 | 2015 | 8 | 0.120 |
Why?
|
| Monophenol Monooxygenase | 1 | 2015 | 14 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2015 | 638 | 0.110 |
Why?
|
| Oxazines | 1 | 2015 | 32 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2015 | 84 | 0.110 |
Why?
|
| Coumarins | 1 | 2015 | 45 | 0.110 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 12 | 0.110 |
Why?
|
| Genistein | 1 | 2015 | 45 | 0.110 |
Why?
|
| Chorioallantoic Membrane | 1 | 2014 | 11 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 28 | 0.110 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 95 | 0.110 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.110 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 280 | 0.110 |
Why?
|
| Laminin | 1 | 2014 | 58 | 0.110 |
Why?
|
| Cell-Free System | 1 | 2014 | 15 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2014 | 49 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 72 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2014 | 104 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 458 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 62 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 80 | 0.100 |
Why?
|
| Glutarates | 1 | 2013 | 4 | 0.100 |
Why?
|
| Oximes | 1 | 2013 | 7 | 0.100 |
Why?
|
| Oxadiazoles | 1 | 2013 | 15 | 0.100 |
Why?
|
| Alphavirus | 1 | 2013 | 10 | 0.100 |
Why?
|
| Anopheles | 1 | 2013 | 21 | 0.100 |
Why?
|
| Tubulin | 1 | 2014 | 96 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 367 | 0.100 |
Why?
|
| Collagen | 1 | 2014 | 181 | 0.100 |
Why?
|
| Aromatase | 1 | 2013 | 20 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2013 | 38 | 0.100 |
Why?
|
| Aromatase Inhibitors | 1 | 2013 | 19 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 42 | 0.100 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 36 | 0.100 |
Why?
|
| Insect Proteins | 1 | 2013 | 53 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1003 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 78 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 34 | 0.100 |
Why?
|
| Vimentin | 1 | 2013 | 44 | 0.100 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 27 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 1596 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2012 | 14 | 0.100 |
Why?
|
| Amides | 1 | 2013 | 71 | 0.090 |
Why?
|
| Taxoids | 1 | 2013 | 50 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 139 | 0.090 |
Why?
|
| Fundulidae | 1 | 2012 | 7 | 0.090 |
Why?
|
| Regeneration | 1 | 2012 | 32 | 0.090 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 10 | 0.090 |
Why?
|
| Ethinyl Estradiol | 1 | 2012 | 11 | 0.090 |
Why?
|
| New Orleans | 1 | 2012 | 17 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2014 | 321 | 0.090 |
Why?
|
| Binding Sites | 1 | 2014 | 671 | 0.090 |
Why?
|
| Receptors, Leptin | 1 | 2012 | 14 | 0.090 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2012 | 21 | 0.090 |
Why?
|
| Macaca mulatta | 1 | 2012 | 139 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2012 | 63 | 0.090 |
Why?
|
| Fresh Water | 1 | 2012 | 48 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 102 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2013 | 169 | 0.090 |
Why?
|
| Cell Division | 1 | 2012 | 311 | 0.090 |
Why?
|
| Seawater | 1 | 2012 | 54 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 102 | 0.090 |
Why?
|
| Mississippi | 1 | 2012 | 129 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2012 | 165 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 50 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 81 | 0.090 |
Why?
|
| Pesticides | 1 | 2012 | 62 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 415 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2013 | 174 | 0.090 |
Why?
|
| Cell Survival | 2 | 2019 | 945 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 652 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 133 | 0.080 |
Why?
|
| Phenols | 1 | 2012 | 107 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 667 | 0.080 |
Why?
|
| Leptin | 1 | 2012 | 118 | 0.080 |
Why?
|
| Obesity | 1 | 2019 | 1151 | 0.080 |
Why?
|
| Response Elements | 1 | 2010 | 55 | 0.080 |
Why?
|
| Louisiana | 2 | 2008 | 50 | 0.080 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 104 | 0.080 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 92 | 0.080 |
Why?
|
| Male | 10 | 2022 | 23409 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 704 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 301 | 0.080 |
Why?
|
| Environmental Monitoring | 2 | 2012 | 230 | 0.070 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2008 | 32 | 0.070 |
Why?
|
| Oryzias | 1 | 2008 | 9 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 196 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1271 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2020 | 346 | 0.070 |
Why?
|
| Benzamidines | 1 | 2007 | 5 | 0.070 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2007 | 6 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2019 | 1621 | 0.070 |
Why?
|
| Trypanosomiasis, African | 1 | 2007 | 22 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 592 | 0.070 |
Why?
|
| Cyclonic Storms | 1 | 2008 | 80 | 0.070 |
Why?
|
| Trypanocidal Agents | 1 | 2007 | 40 | 0.070 |
Why?
|
| Soil Pollutants | 1 | 2008 | 105 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 495 | 0.070 |
Why?
|
| Piperazines | 1 | 2007 | 120 | 0.060 |
Why?
|
| Hypochlorous Acid | 1 | 2006 | 3 | 0.060 |
Why?
|
| Secretory Vesicles | 1 | 2006 | 20 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2006 | 21 | 0.060 |
Why?
|
| Phagosomes | 1 | 2006 | 33 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2006 | 28 | 0.060 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2007 | 82 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 436 | 0.060 |
Why?
|
| Oxocins | 1 | 2005 | 3 | 0.060 |
Why?
|
| Phenotype | 1 | 2008 | 780 | 0.060 |
Why?
|
| Marine Toxins | 1 | 2005 | 17 | 0.060 |
Why?
|
| Neutrophils | 1 | 2006 | 145 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2005 | 80 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 611 | 0.060 |
Why?
|
| Kinetics | 2 | 2015 | 695 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2023 | 14 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2023 | 21 | 0.050 |
Why?
|
| Acetylation | 1 | 2023 | 107 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1081 | 0.050 |
Why?
|
| Niclosamide | 1 | 2022 | 9 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2002 | 47 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 131 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 91 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 220 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2019 | 127 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 95 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 408 | 0.040 |
Why?
|
| Tablets | 1 | 2018 | 14 | 0.040 |
Why?
|
| Electrodes | 1 | 2018 | 59 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 144 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 411 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 160 | 0.030 |
Why?
|
| Graphite | 1 | 2018 | 64 | 0.030 |
Why?
|
| Adsorption | 1 | 2016 | 74 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2016 | 32 | 0.030 |
Why?
|
| Catalysis | 1 | 2016 | 187 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 434 | 0.030 |
Why?
|
| Nanotubes, Carbon | 1 | 2016 | 87 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 50 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 49 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 98 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 310 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 149 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 240 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2014 | 39 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2014 | 54 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2014 | 57 | 0.030 |
Why?
|
| Bioartificial Organs | 1 | 2014 | 2 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 79 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2015 | 204 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2014 | 45 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 508 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 163 | 0.030 |
Why?
|
| Oxygen | 1 | 2015 | 218 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 101 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 145 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 457 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 224 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2014 | 75 | 0.020 |
Why?
|
| Fixatives | 1 | 2012 | 7 | 0.020 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2012 | 8 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 2012 | 8 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 71 | 0.020 |
Why?
|
| Detergents | 1 | 2012 | 25 | 0.020 |
Why?
|
| Perfusion | 1 | 2012 | 38 | 0.020 |
Why?
|
| Prostate | 1 | 2014 | 155 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2012 | 24 | 0.020 |
Why?
|
| Deoxyribonucleases | 1 | 2012 | 27 | 0.020 |
Why?
|
| Gills | 1 | 2012 | 14 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2012 | 54 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 238 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 296 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 694 | 0.020 |
Why?
|
| Lipids | 1 | 2013 | 256 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 143 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 220 | 0.020 |
Why?
|
| Nanostructures | 1 | 2013 | 161 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 172 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1180 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 316 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 592 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 2008 | 24 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1766 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1082 | 0.020 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2007 | 15 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2007 | 96 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2006 | 33 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2006 | 86 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 63 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 97 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2005 | 168 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 185 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 536 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 595 | 0.010 |
Why?
|